PDL BIOPHARMA INC's ticker is and the CUSIP is 69329YAG9. A total of 15 filers reported holding PDL BIOPHARMA INC in Q3 2019. The put-call ratio across all filers is - and the average weighting 1.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2019 | $19,603,000 | +26.4% | 18,585,000 | +37.3% | 0.03% | +28.0% |
| Q1 2019 | $15,511,000 | +21.9% | 13,532,000 | +8.3% | 0.02% | +8.7% |
| Q4 2018 | $12,721,000 | +32.9% | 12,500,000 | +29.5% | 0.02% | +53.3% |
| Q3 2018 | $9,571,000 | +7.4% | 9,650,000 | 0.0% | 0.02% | 0.0% |
| Q2 2018 | $8,908,000 | -12.0% | 9,650,000 | -2.5% | 0.02% | -11.8% |
| Q1 2018 | $10,127,000 | +4.7% | 9,900,000 | -1.0% | 0.02% | 0.0% |
| Q4 2017 | $9,668,000 | +22.5% | 10,000,000 | +37.9% | 0.02% | +21.4% |
| Q3 2017 | $7,893,000 | -23.5% | 7,250,000 | -36.4% | 0.01% | -26.3% |
| Q2 2017 | $10,324,000 | -26.1% | 11,408,000 | -28.7% | 0.02% | -26.9% |
| Q1 2017 | $13,976,000 | +15.2% | 16,008,000 | +6.7% | 0.03% | +4.0% |
| Q4 2016 | $12,128,000 | – | 15,008,000 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SMH CAPITAL ADVISORS INC | 12,804,000 | $12,636,000 | 21.66% |
| Context Partners Fund, L.P. | 7,175,000 | $7,034,000 | 4.09% |
| Context Capital Management, LLC | 7,175,000 | $7,034,000 | 4.09% |
| Pinnacle Holdings, LLC | 3,260,000 | $3,217,213,000 | 1.11% |
| Venator Capital Management Ltd. | 2,000,000 | $1,960,000 | 0.98% |
| LINDEN ADVISORS LP | 26,617,000 | $26,292,000 | 0.80% |
| WHITEBOX ADVISORS LLC | 21,681,000 | $21,396,000 | 0.65% |
| WOLVERINE ASSET MANAGEMENT LLC | 16,852,000 | $16,518,000 | 0.19% |
| OAKTREE CAPITAL MANAGEMENT LP | 4,695,000 | $4,657,000 | 0.06% |
| AQR Arbitrage LLC | 3,150,000 | $3,124,000 | 0.04% |